TIL: Instil Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for TIL
Across the 5 sessions after earlier TIL headlines, the stock closed higher 2 times and lower 3 times, with a median move of 7.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TIL | SPY |
|---|---|---|---|
| May 15, 2026 | Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update | +0.3% | -1.2% |
| Mar 27, 2026 | Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | -6.8% | -1.7% |
| Jan 7, 2026 | Instil Bio downgraded by H.C. Wainwright | +7.8% | -0.3% |
| Jan 6, 2026 | Instil Bio downgraded by Robert W. Baird with a new price targetand 1 other headline that session | -45.8% | +0.6% |
| Nov 13, 2025 | Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update | -7.2% | -1.7% |
Quantisnow market dataNASDAQ
TIL
Instil Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for TIL
Full TIL profile on Quantisnow Follow TIL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time